Cargando…
Role of cytokines in combinatorial immunotherapeutics of non‐small cell lung cancer through systems perspective
Lung cancer is the leading cause of deaths related to cancer and accounts for more than a million deaths per year. Various new strategies have been developed and adapted for treatment; still the survival for 5 years is just 16% in patients with non‐small cell lung cancer (NSCLC). Most of these strat...
Autores principales: | Misra, Pragya, Singh, Shailza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536974/ https://www.ncbi.nlm.nih.gov/pubmed/30997737 http://dx.doi.org/10.1002/cam4.2112 |
Ejemplares similares
-
Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis
por: Khilwani, Riya, et al.
Publicado: (2023) -
The roles of MASPIN expression and subcellular localization in non-small cell lung cancer
por: Wang, Xiao-Fei, et al.
Publicado: (2020) -
Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies
por: Malik, Parth, et al.
Publicado: (2023) -
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
por: Seyfrid, Mathieu, et al.
Publicado: (2022) -
Combinatorial approaches for mitigating resistance to KRAS-targeted therapies
por: Warren, Hannah R., et al.
Publicado: (2022)